Creating end-to-end health programs for GLP-1 users: GLP-1 therapy creates needs beyond medication, prompting demand for integrated health frameworks
It is something else
Despite the potential for problems in the short term, we believe these drugs represent a massive market with opportunities for mid- and small-cap companies
Here's a quick comparison: While dosing schedules appear similar, retatrutide's triple-receptor mechanism (GLP-1 + GIP + glucagon) produces different effects than dual-agonists like tirzepatide or single-agonists like semaglutide
Sustained intracellular growth signaling environment: Because of its extended activity and direct receptor binding, IGF-1 LR3 creates a more persistent intracellular growth signal in experimental systems
Tanning without sunburn, even for fair-skinned individuals Possible reduction in the risk of Melanoma (skin cancer) Possible reduction in the incidence of sun-damaged skin Possible reduction in body fat No sunburn, n tan lines No sunless tanning streaks or fake tan removal Possible increase libido During clinical trials for its use as a tanning agent, melanotan II was found to be a potent stimulator of male erections